Celgene Corporation (CELG): Today's Featured Health Care Winner

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Celgene Corporation ( CELG) pushed the Health Care sector higher today making it today's featured health care winner. The sector as a whole closed the day up 2.3%. By the end of trading, Celgene Corporation rose $6.97 (4.7%) to $156.88 on average volume. Throughout the day, 3,868,338 shares of Celgene Corporation exchanged hands as compared to its average daily volume of 2,954,700 shares. The stock ranged in a price between $150.00-$157.18 after having opened the day at $150.65 as compared to the previous trading day's close of $149.91. Other companies within the Health Care sector that increased today were: Cytokinetics ( CYTK), up 26.1%, Arrowhead Research Corporation ( ARWR), up 18.6%, Sunesis Pharmaceuticals ( SNSS), up 18.3% and Puma Biotechnology ( PBYI), up 18.2%.

Celgene Corporation discovers, develops, and commercializes therapies for cancer and immune-inflammatory related diseases in the United States and Europe. Celgene Corporation has a market cap of $62.2 billion and is part of the drugs industry. Shares are down 11.3% year to date as of the close of trading on Thursday. Currently there are 24 analysts that rate Celgene Corporation a buy, no analysts rate it a sell, and 3 rate it a hold.

TheStreet Ratings rates Celgene Corporation as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, notable return on equity, reasonable valuation levels, solid stock price performance and expanding profit margins. We feel these strengths outweigh the fact that the company has had sub par growth in net income.

On the negative front, Prima Biomed ( PBMD), down 17.6%, Pro-Dex ( PDEX), down 12.2%, Retractable Technologies ( RVP), down 9.2% and Prana Biotechnology ( PRAN), down 8.8% , were all laggards within the health care sector with Cigna ( CI) being today's health care sector laggard.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care ( RXD).

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

If you liked this article you might like

How I've Prepared for Hurricane Irma -- and a Market Pullback

How I'm Prepared for Irma -- and a Pullback

Juno, bluebird In Focus as Targets Following Gilead-Kite Aquisition

Apple Is the Tom Brady of Stocks: Cramer's 'Mad Money' Recap (Thursday 8/31/17)

Cramer: Fantasy Shmantasy -- Let's Get Real With These Stock Picks